Serum Albumin < 2.5 g/dL
45.0
Serum albumin >= 2.8 g/dL
55.0
Albumin >= 3 g/dL, within 14 days of registration and within 7 days of the start of treatment
180.0
Serum albumin >= 2.8 g/dL
42.0
Serum albumin >= 28 g/L
72.0
Serum albumin >= 2.5 g/dL
97.0
Patients must have a serum albumin >= 2.5 g/dL within 28 days prior to registration
97.0
Albumin >= 2.5 g/dL
30.0
Serum albumin >= 2 g/dL
77.0
Albumin >= 2.5 g/dL
40.0
Albumin >= 2.5 g/dL
130.0
Serum albumin >= 2 g/dL
154.0
Albumin >= 2.5 g/dL
250.0
Serum albumin >= 3 g/dL
40.0
Patients on Part A and Part B: serum albumin >= 2 g/dL
148.0
Patients on Part C with ALL: serum albumin >= 2 g/dL
148.0
Albumin >= 2.5 mg/dl
182.0
Albumin >= 2.5 g/dL
35.0
Serum albumin >= 2.5 g/dL
280.0
Serum albumin >= 2.8 g/dL
90.0
Albumin >= 2.5 g/dL
18.0
Serum albumin >= 2.8 g/dL
135.0
Serum albumin >= 2 g/dL
81.0
Albumin >= 2.8 g/dL
96.0
Albumin >= 2 g/dl
110.0
INCLUSION CRITERIA FOR STRATUM C: Albumin >= 2 g/dl
110.0
Serum albumin >= 2 g/dL
67.0
Serum albumin >= 2 g/dL
44.0
Serum albumin >= 3 g/dL
150.0
Within 14 days prior to registration: Serum albumin >= 3.0 g/dL
143.0
Serum albumin >= 2 g/dL
65.0
Serum albumin >= 2 g/dl
36.0
Albumin >= 2 g/dl
25.0
Serum albumin >= 2.8 g/dL
146.0
Serum albumin >= 2 g/dL
51.0
Patients with hypersensitivity to albumin are not eligible
51.0
Albumin >= 2.5 g/dL within 28 days prior to registration
64.0
Albumin >= 2.5 g/dl
186.0
Albumin >= 2.5 g/dL within 30 days of day 1 of study
27.0
Patients with solid tumors: serum albumin >= 2 g/dL
49.0
Serum albumin >= 2 g/dL
98.0
Serum albumin >= 2 g/dL
49.0
Serum albumin >= 2 g/dL
49.0
Serum albumin >= 2 g/dL
144.0
Serum albumin >= 2 g/dL within 7 days prior to enrollment
49.0
